Dela Torre, Hazzel B.

HRN: 28-47-32  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/22/2026
CEFUROXIME 500MG (TAB)
02/22/2026
02/28/2026
ORAL
500mg
BID X 7days
Sp CS
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines